3rd Annual CRISPR Precision Genome Editing Congress Boston will once again unite academia, pharma, biotech and technology providers to optimize the adoption of CRISPR gene editing and pioneer further advances within biomedical research, drug discovery, R&D and therapeutic development.
Cut through the avalanche of publications and ensure your CRISPR workflows are properly customized and harness the latest approaches to improve efficiency, increase specificity to minimize off-target effects and overcome key delivery challenges.
"This is designed to describe the profound impact CRISPR is having on basic research and therapeutic development. It will explore what's needed to make the most of this breakthrough technology." Eric Rhodes, Horizon